SCHEMBL7690197

SCHEMBL7690197

CCCCC(NC(=O)c1ccccc1C=Cc1ccc(CN2CCCC2)cc1)C(=O)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 8/20 0.51
CTSB P07858 5/20 0.51
CTSS P25774 2/20 0.41
CTSK P43235 2/20 0.41
CTSL P07711 2/20 0.39
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HRH3 Q9Y5N1 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
HTR7 P34969 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
KDM1A O60341 1/20 0.36
EHMT2 Q96KQ7 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697381 0.99 CAPN1 (0.50) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697236 0.96 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697613 0.95 CAPN1 (0.52) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7694145 0.94 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691261 0.89 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697278 0.88 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695233 0.88 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693169 0.87 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696093 0.86 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7690557 0.86 CAPN1 (0.52) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed